KAMAL CHANTAL: Open Payments
NPI 1104817568 · LYNCHBURG, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,499 in 75 payments from 12 companies in 2025. Trend: 2023 $1,405 · 2024 $1,560 · 2025 $1,499
Food & beverage: $1,399Education: $100
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 18 | $349 |
| Janssen Biotech, Inc. | 21 | $343 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 11 | $218 |
| Novartis Pharmaceuticals Corporation | 8 | $191 |
| LEO Pharma Inc. | 4 | $91 |
| GENZYME CORPORATION | 3 | $78 |
| UCB, Inc. | 2 | $61 |
| Amgen Inc. | 3 | $54 |
| Arcutis Biotherapeutics, Inc. | 2 | $38 |
| Regeneron Healthcare Solutions, Inc. | 1 | $30 |
Products named: TREMFYA, SKYRIZI, COSENTYX, RINVOQ, DUPIXENT, ILUMYA, ADBRY, Bimzelx.
Industry payments across VA — which companies pay providers there.
